Overview
Status
Active
Registry date
2022-07-08
Share capital
5,000.00 PLN
Registered address
ul. Łabędzia 37, 83-200 Starogard Gdański, Poland
Electronic delivery address
AE:PL-39443-38841-ESDHA-32
Financials
Revenue history (in k)
Filing timeliness
Financial statements were filed on time, on average 22 days early.
- 202524/05/2026
- 202429/06/2025
- 202328/06/2024
- 202214/07/2023
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 147.26kMedianUSD 287.80kAverageUSD 4.90m
Net profit
This companyUSD -6.42kMedianUSD 12.59kAverageUSD 208.64k
Operating costs
This companyUSD 153.62kMedianUSD 272.78kAverageUSD 4.48m
Assets
This companyUSD 25.17kMedianUSD 224.38kAverageUSD 5.76m
Industry
Authorized Representatives
Adam Stasiszyn – President of the Management Board
Manner of representation
Each member of the management board is authorized to make declarations on behalf of the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Michalina Gabriela Kolassaage 36 | 30 | $405.19 | 30% |
Adam Stasiszynage 39 | 70 | $945.43 | 70% |
Beneficial owners
| Person | Rights |
|---|---|
Debt
No entries in the National Debtors Register (KRZ).
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Nov 14, 2024 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $7,663$7,663 | STAROSTA POWIATU STAROGARDZKIEGO |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Biovicosp. z o.o. | $32,559,077.90 | biovico.com | ||
| Esvicosp. z o.o. | $1,710,090.76 | esvimed.pl | ||
| Optyk Plussp. z o.o. | $971,746.64 | optyk-plus.pl | ||
| Implaisp. z o.o. | $661,746.96 | implai.com | ||
| Pressdots Technologysp. z o.o. | $270,666.62 | pressdots.pl | ||
| Your Labsp. z o.o. | $198,230.62 | yourlab.pl | ||
| Medical InventiS.A. | $179,747.04 | medicalinventi.pl | ||
| Markdentsp. z o.o. | $129,752.97 | mark-dent.pl | ||
| Simonsp. z o.o. | $123,787.79 | simonseat.com | ||
| Astendsp. z o.o. | $105,928.35 | astend.pl |
FAQ
The main business activity of Incisal focuses on manufacture of medical and dental instruments and supplies.
The company was registered in the Polish National Court Register (KRS) on July 8, 2022.
The headquarters is located at: ul. Łabędzia 37, 83-200 Starogard Gdański.
The share capital of the company is PLN 5,000 (approx. $1,351).
The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.
In 2025, the company generated total revenue of $147,263, representing an increase of 6.5% compared to 2024.
No, the company recorded a net loss of $6,420 in 2025. For comparison, in 2024 the loss was $7,657, meaning the company reduced its loss by 16.3%.
The largest operating cost category falls under employee remuneration. This category amounted to $87,746 in 2025, representing 57% of all operating expenses.
Last updated: 2026-05-24